A Clinical Trial to Evaluate the Safety and Immunogenicity of BG505 MD39.3, BG505 MD39.3 gp151, and BG505 MD39.3 gp151 CD4KO HIV Trimer mRNA Vaccines in Healthy, HIV-uninfected Adult Participants
Clinical trial NCT05217641 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05217641
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-11
- Primary completion
- 2023-07-17
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.